de Sequera Ortiz Patricia, Pérez García Rafael, Molina Nuñez Manuel, Muñoz González Rosa Inés, Álvarez Fernández Gracia, Mérida Herrero Eva, Camba Caride María Jesús, Blázquez Collado Luís Alberto, Alcaide Lara M Paz, Echarri Carrillo Rocío
Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, España.
Servicio de Nefrología, Hospital Universitario Infanta Leonor, Madrid, España.
Nefrologia (Engl Ed). 2019 Jul-Aug;39(4):424-433. doi: 10.1016/j.nefro.2018.11.002. Epub 2019 Jan 24.
Dialysis fluid (DF), an essential element in hemodialysis (HD), is manufactured in situ by mixing three components: treated water, bicarbonate concentrate and acid concentrate. To avoid the precipitation of calcium and magnesium carbonate that is produced in DF by the addition of bicarbonate, it is necessary to add an acid. There are 2 acid concentrates that contain acetate (ADF) or citrate (CDF) as a stabilizer.
To compare the acute effect of HD with CDF vs. ADF on the metabolism of calcium, phosphorus and magnesium, acid base balance, coagulation, inflammation and hemodynamic stability.
Prospective, multicenter, randomized and crossed study, of 32 weeks duration, in patients in three-week HD, AK-200-Ultra-S or Artis monitor, 16 weeks with ADF SoftPac, prepared with 3mmol/L of acetate, and 16 weeks with CDF SelectBag Citrate, with 1mmol/L of citrate. Patients older than 18 years were included in HD for a minimum of 3 months by arteriovenous fistula. Epidemiological, dialysis, pre and postdialysis biochemistry, episodes of arterial hypotension, and coagulation scores were collected monthly during the 8 months of the study. Pre and post-dialysis analysis were extracted: venous blood gas, calcium (Ca), ionic calcium (Cai), phosphorus (P), magnesium (Mg) and parathyroid hormone (PTH) among others. ClinicalTrials.gov NCT03319680.
We included 56 patients, 47 (84%) men and 9 (16%) women, mean age: 65.3 (16.4) years, technique HD/HDF: 20 (35.7%)/36 (64.3%). We found differences (p<0.05) when using the DF with citrate (C) versus acetate (A) in the postdialysis values of bicarbonate [C: 26.9 (1.9) vs. A: 28.5 (3) mmol/L], Cai [C: 1.1 (0.05) vs. A: 1.2 (0.08) mmol/L], Mg [C: 1.8 (0.1) vs A: 1, 9 (0.2) mg/dL] and PTH [C: 255 (172) vs. 148 (149) pg/mL]. We did not find any differences in any of the parameters measured before dialysis. Of the 4,416 sessions performed, 2,208 in each group, 311 sessions (14.1%) with ADF and 238 (10.8%) with CDF (p<0.01), were complicated by arterial hypotension. The decrease in maximum blood volume measured by Hemoscan biosensor was also lower [-3.4 (7.7) vs -5.1 (8.2)] although without statistical significance.
Dialysis with citrate acutely produces less postdialysis alkalemia and significantly modifies Ca, Mg and PTH. CDF has a positive impact on hemodynamic tolerance.
透析液(DF)是血液透析(HD)中的关键要素,通过将三种成分混合就地制备而成:处理过的水、碳酸氢盐浓缩液和酸浓缩液。为避免因添加碳酸氢盐而在透析液中产生碳酸钙和碳酸镁沉淀,有必要添加一种酸。有两种酸浓缩液,分别含有醋酸盐(ADF)或柠檬酸盐(CDF)作为稳定剂。
比较使用含柠檬酸盐透析液(CDF)与含醋酸盐透析液(ADF)进行血液透析对钙、磷和镁代谢、酸碱平衡、凝血、炎症及血流动力学稳定性的急性影响。
一项为期32周的前瞻性、多中心、随机交叉研究,纳入接受每周3次血液透析的患者,使用AK - 200 - Ultra - S或Artis监测仪,其中16周使用含3mmol/L醋酸盐的ADF SoftPac,16周使用含1mmol/L柠檬酸盐的CDF SelectBag Citrate。纳入年龄大于18岁、通过动静脉内瘘进行血液透析至少3个月的患者。在研究的8个月期间每月收集流行病学、透析、透析前和透析后生化指标、动脉低血压发作情况及凝血评分。提取透析前和透析后的分析数据:静脉血气、钙(Ca)、离子钙(Cai)、磷(P)、镁(Mg)及甲状旁腺激素(PTH)等。ClinicalTrials.gov标识符:NCT03319680。
我们纳入了56例患者,其中男性47例(84%),女性9例(16%),平均年龄:65.3(16.4)岁,血液透析/血液透析滤过技术:20例(35.7%)/36例(64.3%)。我们发现,使用含柠檬酸盐(C)的透析液与含醋酸盐(A)的透析液相比,透析后碳酸氢盐[C:26.9(1.9)对A:28.5(3)mmol/L]、Cai[C:1.1(0.05)对A:1.2(0.08)mmol/L]、Mg[C:1.8(0.1)对A:1,9(0.2)mg/dL]及PTH[C:255(172)对148(149)pg/mL]的值存在差异(p<0.05)。我们未发现透析前测量的任何参数存在差异。在总共进行的4416次透析治疗中,每组2208次,使用ADF的有311次(14.1%)、使用CDF的有238次(10.8%)出现动脉低血压并发症(p<0.01)。通过Hemoscan生物传感器测量的最大血容量下降幅度也较低[-3.4(7.7)对 -5.1(8.2)],尽管无统计学意义。
使用柠檬酸盐进行透析急性产生的透析后碱血症较少,并显著改变钙、镁和甲状旁腺激素水平。含柠檬酸盐透析液(CDF)对血流动力学耐受性有积极影响。